Status:
NOT_YET_RECRUITING
Assessment of QSant™ for Underlying Allograft Rejection
Lead Sponsor:
NephroSant
Conditions:
Kidney Transplant Failure and Rejection
Eligibility:
All Genders
Brief Summary
The AQUA registry is a multi-center observational study to assess the clinical management of kidney transplant recipients (KTRs) with use of the QSant test. QSant is a test based on 6 urinary biomarke...
Detailed Description
The AQUA registry is a multi-center observational study to assess the clinical management of kidney transplant recipients (KTRs) with use of the QSant test. Each participant will be tracked for 24 mon...
Eligibility Criteria
Inclusion
- Kidney transplant recipient, ≤ 90 days post kidney transplant of any age, solitary or combined multi-organ solid transplants which includes a kidney transplant.
- Able to understand risks and requirements of participation and provide informed consent
- Willing and able to comply with the study requirements
Exclusion
- Inability to provide a voided urine sample per collection protocol
- Urological abnormalities such as augmented bladder, ileo-conduits, mitrofanoff, and vesicostomy.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT05282966
Start Date
March 1 2023
End Date
October 1 2026
Last Update
September 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.